These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 24239354)

  • 1. Context-specific BAFF-R signaling by the NF-κB and PI3K pathways.
    Jellusova J; Miletic AV; Cato MH; Lin WW; Hu Y; Bishop GA; Shlomchik MJ; Rickert RC
    Cell Rep; 2013 Nov; 5(4):1022-35. PubMed ID: 24239354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical role of B cell lymphoma 10 in BAFF-regulated NF-κB activation and survival of anergic B cells.
    Yu M; Chen Y; He Y; Podd A; Fu G; Wright JA; Kleiman E; Khan WN; Wen R; Wang D
    J Immunol; 2012 Dec; 189(11):5185-93. PubMed ID: 23087406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conditional Deletion of NF-κB-Inducing Kinase (NIK) in Adult Mice Disrupts Mature B Cell Survival and Activation.
    Brightbill HD; Jackman JK; Suto E; Kennedy H; Jones C; Chalasani S; Lin Z; Tam L; Roose-Girma M; Balazs M; Austin CD; Lee WP; Wu LC
    J Immunol; 2015 Aug; 195(3):953-64. PubMed ID: 26116508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BAFF promotes T cell activation through the BAFF-BAFF-R-PI3K-Akt signaling pathway.
    Hu S; Wang R; Zhang M; Liu K; Tao J; Tai Y; Zhou W; Wang Q; Wei W
    Biomed Pharmacother; 2019 Jun; 114():108796. PubMed ID: 30921706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NIK overexpression amplifies, whereas ablation of its TRAF3-binding domain replaces BAFF:BAFF-R-mediated survival signals in B cells.
    Sasaki Y; Calado DP; Derudder E; Zhang B; Shimizu Y; Mackay F; Nishikawa S; Rajewsky K; Schmidt-Supprian M
    Proc Natl Acad Sci U S A; 2008 Aug; 105(31):10883-8. PubMed ID: 18663224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of TRAFs in NF-κB signaling pathways mediated by BAFF.
    Tang X; Zhang L; Wei W
    Immunol Lett; 2018 Apr; 196():113-118. PubMed ID: 29378215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canonical NF-kappaB activity, dispensable for B cell development, replaces BAFF-receptor signals and promotes B cell proliferation upon activation.
    Sasaki Y; Derudder E; Hobeika E; Pelanda R; Reth M; Rajewsky K; Schmidt-Supprian M
    Immunity; 2006 Jun; 24(6):729-739. PubMed ID: 16782029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coordinate suppression of B cell lymphoma by PTEN and SHIP phosphatases.
    Miletic AV; Anzelon-Mills AN; Mills DM; Omori SA; Pedersen IM; Shin DM; Ravetch JV; Bolland S; Morse HC; Rickert RC
    J Exp Med; 2010 Oct; 207(11):2407-20. PubMed ID: 20956547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BAFF enhances chemotaxis of primary human B cells: a particular synergy between BAFF and CXCL13 on memory B cells.
    Badr G; Borhis G; Lefevre EA; Chaoul N; Deshayes F; Dessirier V; Lapree G; Tsapis A; Richard Y
    Blood; 2008 Mar; 111(5):2744-54. PubMed ID: 18172003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B-cell responses to B-cell activation factor of the TNF family (BAFF) are impaired in the absence of PI3K delta.
    Henley T; Kovesdi D; Turner M
    Eur J Immunol; 2008 Dec; 38(12):3543-8. PubMed ID: 19016531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD19 and BAFF-R can signal to promote B-cell survival in the absence of Syk.
    Hobeika E; Levit-Zerdoun E; Anastasopoulou V; Pohlmeyer R; Altmeier S; Alsadeq A; Dobenecker MW; Pelanda R; Reth M
    EMBO J; 2015 Apr; 34(7):925-39. PubMed ID: 25630702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mTOR-Dependent and Independent Survival Signaling by PI3K in B Lymphocytes.
    Kaileh M; Vazquez E; MacFarlane AW; Campbell K; Kurosaki T; Siebenlist U; Sen R
    PLoS One; 2016; 11(1):e0146955. PubMed ID: 26785352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of BAFF/BAFF-R axis in B-cell non-Hodgkin lymphoma.
    Yang S; Li JY; Xu W
    Crit Rev Oncol Hematol; 2014 Aug; 91(2):113-22. PubMed ID: 24629840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRAF2 and TRAF3 signal adapters act cooperatively to control the maturation and survival signals delivered to B cells by the BAFF receptor.
    Gardam S; Sierro F; Basten A; Mackay F; Brink R
    Immunity; 2008 Mar; 28(3):391-401. PubMed ID: 18313334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DYRK1a mediates BAFF-induced noncanonical NF-κB activation to promote autoimmunity and B-cell leukemogenesis.
    Li Y; Xie X; Jie Z; Zhu L; Yang JY; Ko CJ; Gao T; Jain A; Jung SY; Baran N; Konopleva MY; Cheng X; Sun SC
    Blood; 2021 Dec; 138(23):2360-2371. PubMed ID: 34255829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bruton's tyrosine kinase mediates NF-kappa B activation and B cell survival by B cell-activating factor receptor of the TNF-R family.
    Shinners NP; Carlesso G; Castro I; Hoek KL; Corn RA; Woodland RT; Scott ML; Wang D; Khan WN
    J Immunol; 2007 Sep; 179(6):3872-80. PubMed ID: 17785824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The BAFF receptor transduces survival signals by co-opting the B cell receptor signaling pathway.
    Schweighoffer E; Vanes L; Nys J; Cantrell D; McCleary S; Smithers N; Tybulewicz VL
    Immunity; 2013 Mar; 38(3):475-88. PubMed ID: 23453634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease.
    Rickert RC; Jellusova J; Miletic AV
    Immunol Rev; 2011 Nov; 244(1):115-33. PubMed ID: 22017435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential requirement of MALT1 for BAFF-induced outcomes in B cell subsets.
    Tusche MW; Ward LA; Vu F; McCarthy D; Quintela-Fandino M; Ruland J; Gommerman JL; Mak TW
    J Exp Med; 2009 Nov; 206(12):2671-83. PubMed ID: 19917778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B cell receptor-mediated sustained c-Rel activation facilitates late transitional B cell survival through control of B cell activating factor receptor and NF-kappaB2.
    Castro I; Wright JA; Damdinsuren B; Hoek KL; Carlesso G; Shinners NP; Gerstein RM; Woodland RT; Sen R; Khan WN
    J Immunol; 2009 Jun; 182(12):7729-37. PubMed ID: 19494297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.